439 related articles for article (PubMed ID: 19262545)
1. Proton pump inhibitor failure--what are the therapeutic options?
Fass R
Am J Gastroenterol; 2009 Mar; 104 Suppl 2():S33-8. PubMed ID: 19262545
[TBL] [Abstract][Full Text] [Related]
2. Management of heartburn not responding to proton pump inhibitors.
Fass R; Sifrim D
Gut; 2009 Feb; 58(2):295-309. PubMed ID: 19136523
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic options for refractory gastroesophageal reflux disease.
Fass R
J Gastroenterol Hepatol; 2012 Apr; 27 Suppl 3():3-7. PubMed ID: 22486864
[TBL] [Abstract][Full Text] [Related]
4. Management of gastroesophageal reflux disease that does not respond well to proton pump inhibitors.
Hershcovici T; Fass R
Curr Opin Gastroenterol; 2010 Jul; 26(4):367-78. PubMed ID: 20571388
[TBL] [Abstract][Full Text] [Related]
5. Comparison of the degree of duodenogastroesophageal reflux and acid reflux between patients who failed to respond and those who were successfully treated with a proton pump inhibitor once daily.
Gasiorowska A; Navarro-Rodriguez T; Wendel C; Krupinski E; Perry ZH; Koenig K; Moty B; Powers J; Fass R
Am J Gastroenterol; 2009 Aug; 104(8):2005-13. PubMed ID: 19491829
[TBL] [Abstract][Full Text] [Related]
6. Weakly acidic reflux.
Tack J; Blondeau K
Dig Dis; 2009; 27(1):58-61. PubMed ID: 19439962
[TBL] [Abstract][Full Text] [Related]
7. An algorithm for diagnosis and treatment of refractory GERD.
Hershcovici T; Fass R
Best Pract Res Clin Gastroenterol; 2010 Dec; 24(6):923-36. PubMed ID: 21126704
[TBL] [Abstract][Full Text] [Related]
8. Addition of a H2 receptor antagonist to PPI improves acid control and decreases nocturnal acid breakthrough.
Mainie I; Tutuian R; Castell DO
J Clin Gastroenterol; 2008 Jul; 42(6):676-9. PubMed ID: 18496394
[TBL] [Abstract][Full Text] [Related]
9. Esophageal pH-impedance monitoring in patients with therapy-resistant reflux symptoms: 'on' or 'off' proton pump inhibitor?
Hemmink GJ; Bredenoord AJ; Weusten BL; Monkelbaan JF; Timmer R; Smout AJ
Am J Gastroenterol; 2008 Oct; 103(10):2446-53. PubMed ID: 18684197
[TBL] [Abstract][Full Text] [Related]
10. Evolving drugs in gastroesophageal reflux disease: pharmacologic treatment beyond proton pump inhibitors.
Johnson DA; Levy BH
Expert Opin Pharmacother; 2010 Jun; 11(9):1541-8. PubMed ID: 20450445
[TBL] [Abstract][Full Text] [Related]
11. Medical therapy for gastroesophageal reflux disease in 2007.
Katz PO
Rev Gastroenterol Disord; 2007; 7(4):193-203. PubMed ID: 18192955
[TBL] [Abstract][Full Text] [Related]
12. Long-term gastroesophageal reflux disease therapy improves reflux symptoms in elderly patients: five-year prospective study in community medicine.
Miyamoto M; Haruma K; Kuwabara M; Nagano M; Okamoto T; Tanaka M
J Gastroenterol Hepatol; 2007 May; 22(5):639-44. PubMed ID: 17444849
[TBL] [Abstract][Full Text] [Related]
13. Does the presence of a hiatal hernia affect the efficacy of the reflux inhibitor baclofen during add-on therapy?
Beaumont H; Boeckxstaens GE
Am J Gastroenterol; 2009 Jul; 104(7):1764-71. PubMed ID: 19491837
[TBL] [Abstract][Full Text] [Related]
14. Refractory gastrooesophageal reflux disease.
Bredenoord AJ; Smout AJ
Eur J Gastroenterol Hepatol; 2008 Mar; 20(3):217-23. PubMed ID: 18301303
[TBL] [Abstract][Full Text] [Related]
15. Emerging drugs for gastroesophageal reflux disease.
Boeckxstaens GE
Expert Opin Emerg Drugs; 2009 Sep; 14(3):481-91. PubMed ID: 19650746
[TBL] [Abstract][Full Text] [Related]
16. Alternative therapeutic approaches to chronic proton pump inhibitor treatment.
Fass R
Clin Gastroenterol Hepatol; 2012 Apr; 10(4):338-45; quiz e39-40. PubMed ID: 22178462
[TBL] [Abstract][Full Text] [Related]
17. Recent developments in the pathophysiology and therapy of gastroesophageal reflux disease and nonerosive reflux disease.
Tack J
Curr Opin Gastroenterol; 2005 Jul; 21(4):454-60. PubMed ID: 15930988
[TBL] [Abstract][Full Text] [Related]
18. Medical treatments of GERD: the old and new.
Vela MF
Gastroenterol Clin North Am; 2014 Mar; 43(1):121-33. PubMed ID: 24503363
[TBL] [Abstract][Full Text] [Related]
19. On-demand requirements of patients with endoscopy-negative gastro-oesophageal reflux disease: H2-blocker vs. proton pump inhibitor.
Juul-Hansen P; Rydning A
Aliment Pharmacol Ther; 2009 Jan; 29(2):207-12. PubMed ID: 19006541
[TBL] [Abstract][Full Text] [Related]
20. Step-by-step management of refractory gastresophageal reflux disease.
Hershcovici T; Fass R
Dis Esophagus; 2013 Jan; 26(1):27-36. PubMed ID: 22309405
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]